Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x100px
Document › Details

Sphere Fluidics Ltd.. (1/15/19). "Press Release: Sphere Fluidics Collaborates with Peak Analysis and Automation to Increase Throughput in Antibody Discovery and Cell Line Development". Cambridge & Farnborough.

Organisations Organisation Sphere Fluidics Ltd.
  Group Sphere Fluidics (Group)
  Organisation 2 Peak Analysis and Automation Ltd. (paa)
  Group Peak Analysis and Automation (paa) (Group)
Products Product Cyto-Mine® Single Cell Analysis System
  Product 2 S-LAB™ plate handler
Index term Index term Sphere Fluidics–Peak Analysis and Automation: lab automation technology, 201901– collab integration of S-LAB plate handler with Cyto-Mine system
Persons Person Craig, Frank F. (Sphere Fluidics 2010–202404 CEO + Co-Founder RETIRED 2024/04)
  Person 2 Crook, Malcom (Peak Analysis and Automation 201901 Technical Director)
     


PAA’s S-LAB micro-plate handling capability will be integrated with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System


Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leader in the industry for the design and manufacture of automated laboratory equipment, will collaborate to offer automated micro-plate handling capabilities for single cell analysis. PAA’s S-LAB™ plate handler will be integrated with Sphere Fluidics’ Cyto-Mine® Single Cell Analysis System to help increase throughput in antibody discovery and cell line development.

Sphere Fluidics’ Cyto-Mine is an automated platform which combines single cell screening, sorting, isolation and clone verification, alleviating the need for separate instruments. Its application programming interface (API), introduced as part of the updated Cyto-Mine Studio Software Suite in 2018, enables easy communication with PAA’s innovative S-LAB automated plate handler. The integration of micro-plate handling with the Cyto-Mine will help to reduce hands-on intervention to further streamline biopharmaceutical workflows.

Dr Frank Craig, CEO, Sphere Fluidics, commented: “Our Cyto-Mine is compatible with 96- and 384-well microtiter plates, providing a high-throughput platform for single cell analysis. By combining this with the easy-to-use automated plate handler from Peak Analysis and Automation we will be able to offer improved throughput capabilities to help reduce timelines in biotherapeutic discovery and cell-line development.”

Dr Malcolm Crook, Technical Director, Peak Analysis and Automation, said: “Our small, affordable plate handler with the reliability of a robotic arm will offer users of Sphere Fluidics’ award-winning Cyto-Mine system a simple and flexible solution to further improve workflows and reduce costs associated with a more labor-intensive approach.”

Cyto-Mine will be on display in Washington, DC at SLAS 2019 from 2nd to 6th February 2019 (Booth #1655 and #1429).

For further information about Sphere Fluidics and Cyto-Mine, please visit: https://spherefluidics.com/products/integrated-systems/cyto-mine/

For further information about PAA’s lab automation systems, please visit: https://www.paa-automation.com/products/automated-platehandlers/

   
Record changed: 2023-06-05

Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x200px

More documents for Sphere Fluidics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture biomindz Brand LSE Mainz Place to Biotech 650x300px




» top